A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, ...

Sara Penuela Rodriguez (left), an interdisciplinary neuroscience doctoral student, administers infrared laser light therapy ...

It is narked not only by motor symptoms – such as tremors, stiffness, and bradykinesia – but also by cognitive decline. PD is also characterized by the degeneration and death of nerve cells in the ...

The company completed a clinical trial at nine centers across the U.S., Europe and Asia before it received FDA approval.

Ambroxol increased enzyme levels in Parkinson’s dementia patients, but showed no cognitive benefit in a year-long trial.

Muscle stiffness, or rigidity, is another common early sign. It can happen in the arms, legs, or body and may feel like ...

In those nations, MAID is available to a wider universe of pained people, not just those with fewer than six months to live.

A new study from Stanford Medicine has found that stopping an overactive enzyme in the brain might help protect and even ...

Parkinson's disease is a neurogenerative disease that affects more than 1 million people in the U.S. While some cases are ...

A team of Chicago area scientists discovered that the human pegivirus, a blood-borne virus otherwise not known to cause any specific disease, may be associated with Parkinson’s disease and ...

The drug is Ambroxol. It’s been used for decades to treat respiratory ailments by thinning mucus and easing coughs. But now, ...